Qube Research & Technologies (QRT)
SLDB icon

Qube Research & Technologies (QRT)’s Solid Biosciences SLDB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
+136,903
New +$1.04M ﹤0.01% 2297
2025
Q1 		– Sell
-37,277
Closed -$149K – 3845
2024
Q4 		$149K Sell
37,277
-37,242
-50% -$205K ﹤0.01% 2906
2024
Q3 		$519K Sell
74,519
-174,068
-70% -$1.41M ﹤0.01% 2255
2024
Q2 		$1.41M Buy
248,587
+117,939
+90% +$1.06M ﹤0.01% 1761
2024
Q1 		$1.74M Buy
130,648
+130,647
+13,064,700% +$1.22M ﹤0.01% 1839
2023
Q4 		$6 Hold
1
– – ﹤0.01% 4200
2023
Q3 		$3 Buy
+1
New +$4 ﹤0.01% 3993
2022
Q4 		– Sell
-3,765
Closed -$26K – 2945
2022
Q3 		$26K Sell
3,765
-234
-6% -$2.36K ﹤0.01% 2263
2022
Q2 		$37K Buy
+3,999
New +$41.6K ﹤0.01% 2180
2021
Q3 		– Sell
-6,607
Closed -$363K – 2724
2021
Q2 		$363K Buy
6,607
+3,964
+150% +$262K ﹤0.01% 1461
2021
Q1 		$219K Buy
+2,643
New +$292K ﹤0.01% 1617

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s SLDB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Solid Biosciences (SLDB) in Q2 2026: 136,903 shares worth $1.37M. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in SLDB as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in SLDB in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.74M in Q1 2024. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 136,903 shares of Solid Biosciences worth $1.37M as of Q2 2026.
  • Solid Biosciences was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2297 holding.
  • Qube Research & Technologies (QRT) first reported a position in Solid Biosciences in Q1 2021 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Solid Biosciences position peaked at $1.74M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.